Journal of drugs in dermatology : JDD 2009-08-01

The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.

Chai Sue Lee, John Koo

Index: Journal. of. Drugs in. Dermatology. 8(8) , 751-5, (2009)

Full Text: HTML

Abstract

This study compared the efficacy of a novel, topical class I synthetic, 0.10% fluocinonide corticosteroid with two other class I corticosteroids and placebo for the treatment of plaque psoriasis.A 0.5 gram dose of fluocinonide 0.1% cream, clobetasol propionate 0.05% cream, halobetasol propionate 0.05% cream, and placebo ointment were applied to test sites on one psoriatic plaque per patient (n=5). Test sites were outlined according to the Scholtz-Dumas bioassay. Test sites were assessed by a blinded evaluator (1 = psoriasis worsened to 5 = psoriasis clear or almost clear), cleaned and medications were reapplied on days 3, 5, 7, 10 and 12.The three class I corticosteroid products were comparably effective, numerically and statistically, in clearing the psoriatic plaques. Upon completion of treatment, 60-80% of active-treated sites were clear or almost clear of psoriasis compared to zero with the placebo.


Related Compounds

  • FLUOCINONIDE

Related Articles:

Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis.

2011-02-01

[Journal. of. Drugs in. Dermatology. 10(2) , 171-6, (2011)]

Urticarial hypersensitivity reaction caused by temozolomide.

2010-09-01

[Journal. of. Drugs in. Dermatology. 9(9) , 1142-4, (2010)]

In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.

2008-01-01

[Journal. of. Drugs in. Dermatology. 7(1) , 28-32, (2008)]

Reticulated phototoxic eruption in a patient on long-term diltiazem therapy.

2008-08-01

[Journal. of. Drugs in. Dermatology. 7(8) , 792-3, (2008)]

Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.

2010-10-01

[Cutis. 86(4) , 208-13, (2010)]

More Articles...